Combining Genomics and Imageomics to Predict the Sensitivity of Neoadjuvant Pemetrexed and Cisplatin Chemotherapy in Patients With Lung Adenocarcinoma

Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy

NCT05584267 ·Status: RECRUITING ·Phase: PHASE2

Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer

NCT05925751 ·Status: UNKNOWN

Construction of CT Radiomics Model for Predicting the Efficacy of Immunotherapy in Patients With Stage III NSCLC

NCT04984148 ·Status: UNKNOWN

Circulating Tumor DNA in Surgical Lung Cancer Patients

NCT03081741 ·Status: UNKNOWN

ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS

NCT03172156 ·Status: COMPLETED

Radiomics for prEdiction of lunG cAncer biologY

NCT05819905 ·Status: UNKNOWN

Multi Dimensional Precise Exploration of Immunoconsolidation Therapy for Locally Advanced NSCLC After Chemo-radiotherapy

NCT04741633 ·Status: UNKNOWN

Decoding the Association of Imaging and Tumor Microenvironment in Lung Cancer Using Radiogenomic Approach（Radiogenomics-Lung）

NCT06500312 ·Status: RECRUITING

Exploration of Predictive Markers of Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

NCT05965557 ·Status: RECRUITING

NGS-based Comprehensive Genomic ctDNA Panel in NSCLC With Immunotherapy

NCT04636047 ·Status: UNKNOWN

Multiplex Analysis of Circulating Tumor DNA

NCT03301961 ·Status: UNKNOWN

Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC Patients

NCT04229121 ·Status: UNKNOWN

Dynamic PET/CT Evaluated the Response of Neoadjuvant Anti-PD1 Combination With Chemotherapy for Ⅱa-Ⅲb NSCLC

NCT04586465 ·Status: UNKNOWN ·Phase: PHASE2

Precision Diagnosis for Intraoperative Frozen Section of Early Stage Lung Cancer

NCT02941003 ·Status: UNKNOWN ·Phase: NA

Clinical Evaluation of Genetron Lung Cancer Panel in Non-small Cell Lung Cancer Patients

NCT05023746 ·Status: COMPLETED

Efficacy and Safety of Microwave Ablation Combined With Camrelizumab and Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer: a Multicenter, Open, Prospective Study

NCT05532527 ·Status: UNKNOWN ·Phase: NA

Predictive Value of PET/CT for Efficacy of Neoadjuvant Immunotherapy in Non-small Cell Lung Cancer

NCT06895941 ·Status: WITHDRAWN

Biomarkers of Stage III Locally Advanced Unresectable Non-small-cell Lung Cancer

NCT04749407 ·Status: UNKNOWN

Next-generation Sequencing of Small Cell Lung Cancer to Identify Susceptibility Gene and to Assess Treatment

NCT03244904 ·Status: UNKNOWN

Dynamic Monitoring Circulating Tumor DNA in Surgical Patients With Lung Cancer

NCT03317080 ·Status: UNKNOWN

Deep Learning Signature for Predicting the Novel Grading System of Clinical Stage I Lung Adenocarcinoma

NCT05736991 ·Status: UNKNOWN

PD-L1 PET Imaging in Patients With the Immunotherapy for Non-small Cell Lung Cancer

NCT05533086 ·Status: UNKNOWN

Application of Detecting Circulating Tumor Cells in the Accurate Treatment of Early Stage Lung Adenocarcinoma

NCT02951897 ·Status: UNKNOWN ·Phase: NA

Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer

NCT02202655 ·Status: UNKNOWN

Low-dose Protocol for Computed Tomography-guided Lung Biopsy

NCT02971176 ·Status: COMPLETED ·Phase: NA